Heart Patients' genes may hold key to safer blood thinner use
NCT ID NCT06143709
First seen Jan 16, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study is collecting information from over 1,600 people who have had a heart stent procedure and received genetic testing to guide their blood thinner medication. Researchers want to learn how factors like ancestry and other genes affect treatment success and safety. The goal is to find the best ways to personalize antiplatelet therapy to prevent heart attacks and strokes while reducing bleeding risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32609, United States
Conditions
Explore the condition pages connected to this study.